Literature DB >> 11224631

A 9-year, single-institution, retrospective review of death rate and prognostic factors in adult respiratory distress syndrome.

T R Rocco1, S E Reinert, W Cioffi, D Harrington, G Buczko, H H Simms.   

Abstract

OBJECTIVE: To evaluate, at a single institution, the adult respiratory distress syndrome (ARDS) death rate in critically ill ventilated surgical/trauma patients and to identify the factors predicting death in these patients. SUMMARY BACKGROUND DATA: The prognostic features affecting mortality at the onset of ARDS have not been clearly defined. Defining rare characteristics would be valuable because it would allow for better stratification of patients in clinical trials and more appropriate utilization of constrained resources in ICU environments.
METHODS: A retrospective analysis of 980 ventilated surgical and trauma intensive care unit patients from January 1990 to December 1998 was performed at Rhode Island Hospital. One hundred eleven adult intensive care unit patients with ARDS were identified using the criteria of Lung Injury Score more than 2.50 and the definition from the American-European Consensus Conference. Slightly more than half were trauma patients, 57% were men, and the median age was 59 years. The overall death rate was 52%. Patients were segregated by admission date to the intensive care unit (before or after January 1, 1995). Severity of illness was measured by the Revised Trauma Score for trauma patients and the Acute Physiology and Chronic Health Evaluation III for surgical patients. The Multiple Organ Dysfunction Score was determined on the day of onset of ARDS for all patients. Other recorded variables were age, sex, intensive care unit length of stay, length and mode of ventilation, presence or absence of tracheostomy, ventilation variables of peak and mean airway pressures, lung injury scores, elective versus emergency surgery, and presence or absence of pneumonia.
RESULTS: There was a significant decrease in the ARDS death rate from the period 1990 to 1994 to the period 1995 to 1998. The major reason for the decline was a reduction in the posttraumatic ARDS death rate. Lung-protective ventilation strategies were used more frequently in the second period than in the first, and the death rate was significantly decreased in trauma patients in the second period when lung-protective ventilation modes were used. Predictors of death at the onset of ARDS were advanced age, Multiple Organ Dysfunction Score of 8 or more, and Lung Injury Score of 2.76 or more.
CONCLUSION: In this single-institution series, the death rate from ARDS declined from 1990 to 1998, primarily in posttraumatic patients, and the decrease is related to the use of lung-protective ventilation strategies. Based on this patient population, the authors developed a statistical model to evaluate important prognostic indicators (advanced age, organ system and pulmonary dysfunction measurements) at the onset of ARDS.

Entities:  

Mesh:

Year:  2001        PMID: 11224631      PMCID: PMC1421259          DOI: 10.1097/00000658-200103000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  Futility of randomized, controlled ARDS trials--a new approach is needed.

Authors:  B P Fuhrman; E Abraham; R P Dellinger
Journal:  Crit Care Med       Date:  1999-02       Impact factor: 7.598

Review 2.  The adult respiratory distress syndrome. Definition and prognosis.

Authors:  M A Matthay
Journal:  Clin Chest Med       Date:  1990-12       Impact factor: 2.878

3.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids.

Authors:  G U Meduri; J M Belenchia; R J Estes; R G Wunderink; M el Torky; K V Leeper
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

Review 4.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

5.  A comparison of risks and outcomes for patients with organ system failure: 1982-1990.

Authors:  J E Zimmerman; W A Knaus; D P Wagner; X Sun; R B Hakim; P O Nystrom
Journal:  Crit Care Med       Date:  1996-10       Impact factor: 7.598

6.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

7.  What is acute lung injury? What is ARDS?

Authors:  D P Schuster
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

8.  Acute lung injury at Baragwanath ICU. An eight-month audit and call for consensus for other organ failure in the adult respiratory distress syndrome.

Authors:  P A Kraus; J Lipman; C C Lee; W E Wilson; J Scribante; J Barr; L R Mathivha; J M Brown
Journal:  Chest       Date:  1993-06       Impact factor: 9.410

9.  Identification of patients with acute lung injury. Predictors of mortality.

Authors:  R L Doyle; N Szaflarski; G W Modin; J P Wiener-Kronish; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

10.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09
View more
  12 in total

1.  Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.

Authors:  Cristina M Alvira; Aida Abate; Guang Yang; Phyllis A Dennery; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

2.  A prospective cohort study of ALI/ARDS in the Tohoku district of Japan (second report).

Authors:  Shigeatsu Endo; Shigehiro Shibata; Nobuhiro Sato; Eiji Hashiba; Kimitaka Tajimi; Koji Saito; Kaneyuki Kawamae; Masaki Nakane; Masahiro Murakawa
Journal:  J Anesth       Date:  2010-03-27       Impact factor: 2.078

3.  A simple classification model for hospital mortality in patients with acute lung injury managed with lung protective ventilation.

Authors:  Lisa M Brown; Carolyn S Calfee; Michael A Matthay; Roy G Brower; B Taylor Thompson; William Checkley
Journal:  Crit Care Med       Date:  2011-12       Impact factor: 7.598

4.  Ventilatory strategies in septic patients. Results from a nationwide observational trial.

Authors:  D Schädler; G Elke; C Engel; H Bogatsch; I Frerichs; R Kuhlen; R Rossaint; M Quintel; J Scholz; F M Brunkhorst; M Loeffler; K Reinhart; N Weiler
Journal:  Anaesthesist       Date:  2013-01-16       Impact factor: 1.041

5.  Association between age and acute respiratory distress syndrome development and mortality following trauma.

Authors:  Elizabeth Y Killien; Brianna Mills; Monica S Vavilala; R Scott Watson; Grant E OʼKeefe; Frederick P Rivara
Journal:  J Trauma Acute Care Surg       Date:  2019-05       Impact factor: 3.313

6.  Quality of life in acute respiratory distress syndrome survivors may be no worst than in other ICU survivors.

Authors:  Cristina Granja; Edite Morujão; Altamiro Costa-Pereira
Journal:  Intensive Care Med       Date:  2003-05-27       Impact factor: 17.440

7.  Benchmarking outcomes in the critically injured burn patient.

Authors:  Matthew B Klein; Jeremy Goverman; Douglas L Hayden; Shawn P Fagan; Grace P McDonald-Smith; Andrew K Alexander; Richard L Gamelli; Nicole S Gibran; Celeste C Finnerty; Marc G Jeschke; Brett Arnoldo; Bram Wispelwey; Michael N Mindrinos; Wenzhong Xiao; Shari E Honari; Philip H Mason; David A Schoenfeld; David N Herndon; Ronald G Tompkins
Journal:  Ann Surg       Date:  2014-05       Impact factor: 12.969

8.  Reciprocal congenic lines of mice capture the aliq1 effect on acute lung injury survival time.

Authors:  Daniel R Prows; Amanda P Hafertepen; Abby V Winterberg; William J Gibbons; Scott C Wesselkamper; Jonathan B Singer; Annie E Hill; Joseph H Nadeau; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-26       Impact factor: 6.914

9.  Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry.

Authors:  Jochen Frenzel; Christian Gessner; Torsten Sandvoss; Stefan Hammerschmidt; Wolfgang Schellenberger; Ulrich Sack; Klaus Eschrich; Hubert Wirtz
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

10.  Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock.

Authors:  Shibani Pati; Michael H Gerber; Tyler D Menge; Kathryn A Wataha; Yuhai Zhao; John Adam Baumgartner; Jing Zhao; Phillip A Letourneau; Maria P Huby; Lisa A Baer; John R Salsbury; Rosemary A Kozar; Charles E Wade; Peter A Walker; Pramod K Dash; Charles S Cox; Marie-Francoise Doursout; John B Holcomb
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.